BIOMAT Database Logo BIOMAT Database Logo

Effect of a hepatitis B vaccination program on the prevalence of hepatitis B virus infection. 1993

F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Epidemiology Section, National Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia 30333.

In April 1991, surveys for serologic evidence of hepatitis B virus (HBV) infection were conducted among 3- to 4-year-old children born after a hepatitis B immunization program of newborns began and among 6- to 11-year-old children targeted for early childhood vaccination in American Samoa. Compared with 3- to 4-year-olds tested in 1991, children tested at baseline in 1985 were more likely to have been infected with HBV (5/40 vs. 2/93; prevalence ratio [PR] = 5.8, 95% confidence limits [CL] = 1.2, 28.7) and to have chronic infection with HBV (3/40 vs. 0/95; PR = undefined, lower CL = 1.2). Compared with 6- to 11-year-olds tested in 1991, children in 1985 were more likely to have been infected with HBV (32/121 vs. 53/386; PR = 1.9, CL = 1.3, 2.8) and to have chronic infection with HBV (8/121 vs. 7/386; PR = 3.6, CL = 1.3, 9.8). The incorporation of hepatitis B vaccine into routine childhood vaccination schedules can prevent acute and chronic HBV infection in areas of high endemicity.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014905 Independent State of Samoa An island group and constitutional monarchy in the southwest central Pacific Ocean. The capital is Apia. The islands were jointly administered by England, the United States, and Germany 1889-99, with the chief islands of Savai'i and Upolu recognized as German until 1919. Western Samoa gained independence in 1962 and assumed its present formal name in 1997. Samoa, Independent State,Western Samoa
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D017325 Hepatitis B Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B

Related Publications

F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal.
July 2014, Vaccine,
F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.
September 2013, Vaccine,
F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Effect of a Community-Based Hepatitis B Virus Infection Detection Combined with Vaccination Program in China.
December 2021, Vaccines,
F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Hepatitis B virus infection among Indian tribes: need for vaccination program.
January 2005, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
February 2012, Revista da Sociedade Brasileira de Medicina Tropical,
F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
[Hepatitis B virus infection in a hospital population in Parma: implementation of a vaccination program].
January 1984, Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma,
F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Hepatitis B virus infection: epidemiology and vaccination.
January 2006, Epidemiologic reviews,
F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Effect of obligatory Hepatitis B vaccination program on the prevalence of occult hepatitis B among pregnant women in Egypt: A cross sectional study.
October 2023, The Egyptian journal of immunology,
F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Prevalence of occult hepatitis B virus infection.
March 2011, World journal of gastroenterology,
F J Mahoney, and B A Woodruff, and J J Erben, and P J Coleman, and E C Reid, and G C Schatz, and M A Kane
Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program.
June 1991, Journal of medical virology,
Copied contents to your clipboard!